Commonwealth Equity Services’s Revance Therapeutics, Inc. RVNC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
|
|||||
|
2024
Q4 | $150K | Sell |
|
|||||
|
2024
Q3 | $405K | Sell |
|
|||||
|
2024
Q2 | $282K | Buy |
|
|||||
|
2024
Q1 | $533K | Sell |
|
|||||
|
2023
Q4 | $977K | Buy |
|
|||||
|
2023
Q3 | $1.14M | Buy |
|
|||||
|
2023
Q2 | $2.42M | Buy |
|
|||||
|
2023
Q1 | $2.86K | Sell |
|
|||||
|
2022
Q4 | $1.64M | Buy |
|
|||||
|
2022
Q3 | $2.05M | Buy |
|
|||||
|
2022
Q2 | $453K | Buy |
|
|||||
|
2022
Q1 | $591K | Buy |
|
|||||
|
2021
Q4 | $403K | Buy |
|
|||||
|
2021
Q3 | $589K | Buy |
|
|||||
|
2021
Q2 | $448K | Sell |
|
|||||
|
2021
Q1 | $427K | Buy |
|
|||||
|
2020
Q4 | $373K | Buy |
|
|||||
|
2020
Q3 | $316K | Buy |
|